Objectives: To analyse the epidemiology and genetic evolution of PMEN3 (Spain 9V -156), a penicillinnon-susceptible clone of Streptococcus pneumoniae, causing invasive pneumococcal disease (IPD) in Barcelona during 1987-2016.
Introduction
Invasive pneumococcal disease (IPD) is an important cause of mortality worldwide, mainly affecting children under 5 years old, the elderly and immunocompromised patients. 1, 2 The pneumococcus is a highly recombinant microorganism and its genomic plasticity has given it the ability to respond efficiently to environmental challenges. 3, 4 This has also contributed to the emergence of new genotypes that have ensured its persistence over time, driven by pressure from antimicrobials and the human immune system. The introduction of antibiotics has driven the emergence of b-lactam-resistant and MDR pneumococci since the late 1970s. 5 Even when isolated in different countries, some of these strains have shown close relationships; these were the major successful clones, nomenclature for which was established by the Pneumococcal Molecular Epidemiology Network (PMEN). 6 On the other hand, the pneumococcal capsular polysaccharide is a major virulence factor and has been the basis of vaccine formulation.
In Spain, four pneumococcal vaccines have been licensed: the 23-valent polysaccharide vaccine (PPSV23), from the mid-1980s, and three pneumococcal conjugate vaccines (PCVs; PCV7, PCV10 and PCV13, licensed in 2001, 2009 and 2010, respectively). The introduction of PCVs has led to a worldwide reduction in the incidence of IPD and has changed the epidemiology of pneumococcal serotypes. 2, 7 During the 1990s, four major pneumococcal clones were associated with penicillin resistance in Spain: PMEN1 (Spain 23F -1), PMEN2 (Spain 6B -2), PMEN3 (Spain 9V -3) and PMEN5 (Spain 14 -5). 8 Of these, the extensively studied PMEN1 has been proposed as the donor of antibiotic-resistant determinants. 9 Besides penicillin resistance, the Spanish clones share a high propensity to occur in older people with comorbidities. While PMEN1, PMEN2 and PMEN5 have almost disappeared, PMEN3 has remained prevalent, accounting for up to 10% of all IPD isolates. 10 Originally associated with serotype 9V and ST156, the PMEN3 clone is known to express several capsular types. 8 For example, a serotype 14 variant emerged in the late 1990s and progressively replaced the former MDR serotype 14 clone (PMEN5). 2, 8, 11 Thereafter, the introduction of PCV7 (targeting both the 9V and 14 serotypes) resulted in a sustained reduction in PMEN3 until now, when an increase in isolates has been detected following the emergence of a serotype 11A variant. 12 In this study, we analysed the clinical and molecular epidemiology of the PMEN3 clone over a 30 year period in Barcelona. WGS was used to reveal the successive adaptations of this clone that allowed it to persist over time.
Methods
Bacterial strains, serotyping and antibiotic susceptibility testing
Since 1979, all pneumococci recovered from adult patients admitted to Hospital Universitari de Bellvitge have been prospectively collected as a part of an ongoing research database. However, the first available isolate dates from 1987, so we included IPD isolates collected over a 30 year period from 1987 to 2016. Isolates were identified by conventional methods and serotyped at the Spanish Pneumococcal Reference Laboratory. Antimicrobial susceptibility was tested by microdilution following CLSI methods and criteria. 13 
Molecular typing
Molecular typing was performed by PFGE and MLST. PFGE (SmaI or ApaI) was introduced in our laboratory in 1995 and all available isolates were tested retrospectively. Band patterns were compared with known PMEN clones. 6 A selection of isolates were additionally typed by MLST. 14 
WGS analysis
Forty-six isolates, representing all PMEN3 serotype/genotype combinations and covering the whole period, were studied by WGS (Table S1 , available as Supplementary data at JAC Online). Genomic DNA was extracted using a QIAamp V R DNA Mini Kit (QIAGEN) and adjusted to 0.2 ng/lL using Qubit V R (Thermo Fisher Scientific, USA). Libraries were prepared with Nextera XT V R and multiplexed in two MiSeq runs (Illumina, USA) with a 2%150 bp (paired) read length protocol. The quality of raw data was assessed by FastQC (http://www.bioinfor matics.babraham.ac.uk/projects/fastqc/) and reads were further processed using Geneious 9.1.7 (Biomatters). Ends were trimmed, duplicate reads were removed, errors were corrected and reads were assembled de novo using the Geneious assembler (medium sensitivity).
Initial analyses included the study of differences in SNPs using CSI Phylogeny 1.4. 15 The generated data were subsequently managed with FigTree v1.4.3 (http://tree.bio.ed.ac.uk/software/figtree/). To localize regions with low identity within the chromosome, we constructed a basic local alignment search tool (BLAST) atlas in the CGview Comparison Tool, 16 using the oldest isolate (156_9V_1987) as a reference. Assembled contigs from strain 156_9V_1987 were mapped and annotated according to ATCC 700699, which produced a unique annotated chromosome. The remaining 45 isolates were also mapped to ATCC 700699 and were compared with the inferred chromosome, constructing a BLAST atlas with regions coloured by identity.
In silico analysis included the study of genes encoding resistance to b-lactams (i.e. pbp1a, pbp2x, pbp2b and murM), quinolones (gyrA and parC) and co-trimoxazole (folA and folP). Additionally, a search was performed to identify acquired resistance genes (ResFinder 2.1). 17 Lineages were named based on MLST, serotype and isolation year of the oldest isolate for which we had WGS data (e.g. MLST/serotype/year). The differentiation of lineages within serotype 14 and 9V isolates not included in the WGS analysis was performed by PCR-RFLP (Table S2) .
Raw data were deposited in the European Nucleotide Archive with accession numbers from ERS2201200 to ERS2201245.
Surface protein analysis
Surfotyping was performed based on the presence/absence of full/truncated versions of 17 genes. 18 The genes were detected by Prodigal 19 and annotated using BLAST and the Pfam database. 20 Homologues were aligned by Clustal Omega and Muscle. Phylogenetic trees were created using Mega 7.0 21 and branch quality was estimated by the bootstrap method with 1000 replicates.
Prophage analysis
The genomic sequences were searched for the presence of prophages (or remnants) using PHASTER 22 and lytA-like genes using BLAST, because most (if not all) pneumococcal prophages code for LytA-like lytic endolysins. 23 After finding a phage-like endolysin-coding gene, other potential prophage-coding genes were identified by sequence comparisons in Pfam. 20 
Analysis of clinical characteristics
Clinical data were collected, including age, sex, source of infection, acquisition, comorbidities and 30 day mortality. Differences were analysed by IBM SPSS, Version 23 (IBM Corp., Armonk, NY, USA), using the v 2 test or Fisher's exact test, as appropriate. A two-sided P value of ,0.05 was considered statistically significant.
Ethics
The clinical research ethics committee of Hospital Universitari de Bellvitge approved this research (PR001/18). Written informed consent was not considered necessary and any confidential information was protected according to national standards.
Results

Burden of the PMEN3 clone among adults with IPD in Barcelona
Over the 30 year period, we collected data for 2808 IPD-causing pneumococci. Serotype and molecular typing data were available Càmara et al.
for 2441 isolates (86.9%) and 2136 isolates (76.1%), respectively. Given that the frequency of serotyped/genotyped strains was lower before 1996, the rate of PMEN3 isolates was estimated for that period (Table S3) 
Major genetic differences between lineages
Most genetic regions had a high degree of identity (.99%, blue colours) but there were three regions with significantly lower identity (97%, red colours): the capsular operon and flanking regions (pbp1a and pbp2x genes), the murM region and the pbp2b-ddl region (Table 1 and Figure 3 ). Therefore, we hypothesized that these regions were generated by recombination events and decided to study them in detail. Sequences were aligned, alleles were assigned and regions were compared, using the BLAST algorithm to search for putative donors.
Capsular operon
The capsular operon was identical for all serotype 9V isolates and, in the same way, for all those harbouring capsule 11A. However, some differences were detected among serotype 14 strains, with the nucleotide sequences of lineages 3 (ST44/14/1991) and 5 (ST156/14/ 2001) being identical to each other, but different to those of lineage 4 (ST156/14/1993). These differences consisted of 13 SNPs in the wzg gene (seven amino acid substitutions) and 1 SNP in both the wzh gene and the wzd gene (one amino acid change each). These three genes of the capsular operon of lineages 3 and 5 were identical to PMEN5 (accession number FWTC00000000), whereas those of the lineage 4 isolates differed from PMEN5 and were identical to CGSP14 (accession number CP001033).
pbp1a
Four lineages (1, 2, 3 and 6) harboured a pbp1a gene identical to that of PMEN1 (ATCC 700669, allele A). Lineage 5 harboured a pbp1a that was identical to PMEN5 (ATCC 700902, allele C) and lineage 4 harboured a pbp1a that was identical to URAspn5128, a serotype 14 strain from Portugal (allele B; accession number AM779378). The corresponding PBP1a alleles showed 10 (allele B) and 28 (allele C) amino acid substitutions compared with allele A. 
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The remaining isolates showed SNP variability within this region (Table S4 ).
pbp2b-ddl region
Lineages 1, 3, 4 and 5 shared pbp2b (allele A) and ddl (MLST allele 1) genes with PMEN1. A second group included lineages 2 (ST838/ 9V/1996) and 6 (ST6521/11A/2011) that shared the pbp2b (allele B) and ddl (allele 90) genes. Allele B of pbp2b shared a 98.5% nucleotide identity with Streptococcus mitis B6 (accession number NC_013853) while it had 95% identity with allele A (23 amino acid differences).
murM region
Allele A (closest to PMEN1, with two SNPs) was found in lineages 1, 3 and 4. Allele B was found in lineages 2 and 6 (93% nucleotide identity and 27 amino acid substitutions compared with PMEN1) and was related to the previously described murM allele, murMB5 (nine amino acid differences, 98% nucleotide identity). 24 Allele C was found in lineage 5 (21 amino acid differences and 95% nucleotide identity with the PMEN1 allele).
In silico study of antimicrobial resistance
Detailed information of the results of the in silico study of antimicrobial resistance is shown in Table S4 .
b-Lactams
The original lineage 1 harboured PBPs (1a, 2b and 2x) that were identical to PMEN1 (penicillin non-susceptible), so penicillin nonsusceptibility was deemed characteristic of this clone. It was associated with changes in the main domains of PBP1a (T371A in the STMK373 motif, P432T close to the SRN430 motif and the alteration of four consecutive residues from 574TSQF to 574NTGY), PBP2b (T446A in the 443SSNT motif) and PBP2x (T338A in the 337STMK motif, I371T, and R384G and L546V close to the 547KSG motif). Additionally, an increase in the amoxicillin MIC (from 1-2 to 4-8 mg/L) was observed in lineages 2 and 6 (ST838/9V/1996 and ST6521/11A/2011), which was associated with changes in PBP2b between residues 590 and 641, as previously described. 24 
Quinolones
All except one of the studied isolates were susceptible to levofloxacin and, consequently, only the resistant isolate showed an amino acid substitution related to quinolone resistance (ParC, S79F).
Co-trimoxazole
Co-trimoxazole resistance is associated with mutations in genes coding for dihydropteroate synthetase (folP) and dihydrofolate reductase (folA). Characteristic of PMEN3, all but one isolate were resistant to co-trimoxazole and harboured amino acid substitutions/ insertions associated with resistance in both proteins. Forty-three isolates harboured an Arg insertion (P59GSS!P59GRSS) and two harboured a Ser-Tyr insertion (P59GSS!P59GSSYS) in dihydropteroate synthetase. Additionally, all isolates but two harboured the I100L change in dihydrofolate reductase.
Acquired resistance carried by integrative conjugative elements (ICEs)
Acquired ICEs were detected in five serotype 14 isolates: two harboured the macrolide efflux genetic assembly (mega) element [mef(A) and msr(D)], two had both tet(M) and erm(B) genes associated with the Tn3872 transposon [one of them also had the Xcat (pC194) element] and one harboured a Tn6003 element carrying tet(M), erm(B) and aph(3 0 )-II genes (Table S1 ).
Changes in pneumococcal surface proteins
As intra-clonal phenotypic variability is usually linked to differences in surface proteins, 18 this subset of the proteome was analysed and compared with the lineage structure described above. A total of 28 strains showed an identical profile of accessory genes coding for surface proteins (i.e. cbpJ, cbpL, diiA-long, nanC, rrgB, sp1796, srtD and zmpD genes) as a hallmark of PMEN3 ( Figure S1 ). A notable outlier was a lineage 4 strain (156SLV/14/2007), which lacked genes coding for the StrD and RrgB pilus proteins, but that had acquired PsrP, a virulence factor involved in pulmonary disease via binding to keratin 10. The allelic variability of the seven most immunogenic surface proteins encoded in the core genome was also evaluated (data not shown). 25 Among them, the CbpD variant of lineage 5 isolates, a murein hydrolase involved in competence When compared with the remaining serotype 14 isolates, the capsular operon of the strains of this lineage had 13 SNPs in the wzg gene (seven amino acid substitutions) and 1 SNP in both the wzh gene and the wzd gene (one amino acid change each).
Pneumococcal PMEN3: a 30 year history JAC and fratricide, 26 showed five residue changes (three affecting the peptidoglycan-binding SH3 domain) with respect to the fully conserved variants of the other lineages. Ten isolates also carried an extra homologue of CbpA that showed differences in the aminoterminal region, resulting in a different affinity to factor H, the recruitment of which by CbpA minimizes the activity of the alternative complement pathway and increases the isolate's capacity to evade opsonophagocytosis. 27 
Detection of phage-related proteins
All isolates contained a 13 kb prophage remnant (PG1) and most (n " 41) were polylysogenic. Prophages were classified into five Càmara et al. Table 2 . WP_000876722 (1) WP_050197950 (1) WP_000876726 (1) new alleles (3) WP_024475415 (1) unknown (3) WP_050216447 (1) WP_050225784 ( .40000
WP_000633505 (4) 481 WP_088778480 (1) WP_024478469 (1) WP_000350534 (1) WP_061597704 (1) new alleles (3) unknown (1) a Refers to nt positions and genes of the S. pneumoniae D39 genome (accession number CP000410).
b Two additional att sequences are present in the D39 genome, i.e. between genes SPD_0240 and SPD_0241 (231378-231398) and between genes SPD_0242 and SPD_0243 (233750-233770).
c More than 99% identical to the group 21A prophages described in this study.
d
One additional att sequence is present in the D39 genome between genes SPD_1740 and SPD_1741 (1735090-1735112).
e
The att sequence in D39 is 5
Pneumococcal PMEN3: a 30 year history JAC groups (PG1 to PG5) by their integrase-coding gene (int) and the location of the attachment core sequence (att) in the genome (Table 2 and Figure S2a ). Interestingly, as has previously been observed, 28 two closely related prophages (PG2A and PG2B) were inserted into two different locations in diverse isolates. Although prophages tend to integrate outside of coding sequences, 29 PG3 and PG5 were inserted into the coding regions of SPD_1394 and SPD_1861, respectively. The latter gene encodes for ComGC, the competence pilus major pilin, which is required for transformation. 30, 31 Targeted disruption of competence genes is a mechanism by which mobile elements inhibit transformation events and prevent their elimination. 32 Sequence comparisons with other pneumococcal genomes revealed the existence of similar prophages in otherwise unrelated strains ( Figure S2b ). Sequence alignments showed that only genes like pblB (coding for the phage antireceptor) and those located downstream of pblB and belonging to the lysis module 33 were conserved in all prophages ( Figure S2c) . Although the pblB gene is difficult to assemble with short-read sequence data, as noted previously, two apparently complete pblB genes were found (from PG2 and PG3). When compared with other homologues, the whole sequence diversity of pblB was significant ( Figure S2d) , which is perhaps not surprising since the PblB protein is responsible for interacting with the surface-located phage receptor(s). It should be underlined that whereas .90% amino acid identity existed among the 16 endolysin alleles (not shown), significant differences were found among the 15 different integrases ( Figure S2e) .
Clinical characteristics of patients
Clinical data were available for 212 episodes (Table 3 and  Table S2 ). Most episodes were community acquired (85.8%), involved pneumonia (84.0%) and occurred in patients with at least one comorbidity (84.9%). The overall 30 day mortality was 23.1%. In addition, two findings were remarkable, though without reaching significance. First, the incidence of meningitis and the 30 day mortality were considerably higher for episodes involving serotype 11A. Second, there were fewer patients with comorbidities among IPD episodes due to lineage 4 (67.4%) than other lineages.
Discussion
Streptococcus pneumoniae is a pathogen that has adapted to the changing conditions of its environment. In this paper, we have described the genetic evolution of the PMEN3 clone 6 in Barcelona over a 30 year period, using WGS to explore successive adaptations to the introduction of new antimicrobials and PCVs.
Several major episodes of horizontal DNA transfer were detected in our study (Figure 4) . One of the first was the emergence of a serotype 9V lineage (lineage 2, ST838), which showed increased b-lactam resistance in the 1990s when community use of this antibiotic drug class was extensive. The relationship between oral cephalosporin use and the increase in high-level penicillin resistance has been studied in Spain. 34 However, as the most remarkable difference between the former and the replacing lineage is a significant increase in the amoxicillin MIC (from 1-2 to 4-8 mg/L), the increased aminopenicillin consumption (e.g. amoxicillin/clavulanic acid) could have influenced this replacement. Anyhow, the rise of this lineage was associated with the acquisition of a region including the transpeptidase domain of PBP2b, which was related to S. mitis, highlighting the importance of commensal streptococci as resistance reservoirs. 35 A second major event was the emergence of serotype 14 isolates (lineage 4 ST156/14/1993 and lineage 3 ST44/14/1991) representing one of the first recombination events described for S. pneumoniae. 11 The expansion of these isolates has been related to the rise of penicillin resistance in paediatric cases of IPD in Uruguay (29% in 1994 to 40% in 1997). 36 Notably, these lineages could spread after capsular switching, a phenomenon that did not occur with the sporadic serotypes 19A, 23F or 9N/L. Probably, there are synergisms between serotype and genotype that confer higher invasiveness and likelihood of spread. 37 Focusing on PMEN3, the supremacy of capsular type 14 over 9V, especially in combination with ST156, is supported by several reports linking serotype 14 with invasiveness. 38, 39 However, we were unable to find differences in the clinical characteristics of patients with IPD due to PMEN3 in terms of the lineages or serotypes. The PMEN3 genetic background appeared to have equal clinical invasiveness, irrespective of whether it expressed capsular type 9V, 14 or 11A. WGS was extremely helpful in revealing horizontal DNA transfer events that are not easily recognized by analysing classical markers (e.g. same serotype, MLST and antibiotic profile). For example, ST156 14 isolates were noted to differ in pbp1a and capsular genes in the USA in the late 1990s;
40 using WGS, we were able to Càmara et al.
show that lineages 4 and 5 (serotype 14) emerged independently from the original 156 9V lineage through two different genetic events that led to major differences in pbp1a, pbp2x and murM. Although we were unable to find the putative donors of all regions, the PMEN5 41 clone could be a good candidate to be a donor for lineage 5, at least regarding the capsule and the pbp1a gene that they share. However, the diversity of pbp2x observed among some of the isolates of this lineage suggests that additional recombination occurred. Given that this occurred with serotype 9V and the newest lineage showed higher b-lactam MICs, this again highlighted the role of these antibiotics in pneumococcal evolution.
The latest event detected in the evolution of PMEN3 in Spain has been the emergence of serotype 11A isolates. Although a similar episode was reported in 2000 among pneumococci identified in Israeli children, 42 the isolates reported here seem to have a distinct origin. In fact, WGS analysis shows that they emerged from lineage 2 rather than the original 156 9V clone, which appeared to have been the origin of the isolates from the Israeli children. In Spain, serotype 11A isolates related to PMEN3 emerged in 2004 and spread after the introduction of PCV13. 12 Of note, the use of oral amoxicillin to treat pneumonia could be compromised by the high amoxicillin MICs. Serotype 11A has classically been associated with carriage and low invasiveness, 38, 39 mainly related to CC53 (ST62). Conversely, our data provide evidence for the potential virulence of 11A, indicating high rates in meningitis and in its 30 day mortality. These findings emphasize the importance of the genetic background of PMEN3 to invasiveness. The reduction in mortality during the PCV era has been linked to the decline of PCV7 serotypes 43, 44 and it is likely that the genetic background of the bacteria played a major role. The emergence of an invasive vaccine escape clone linked to high mortality, such as PMEN3 with serotype 11A, is a worrying complication that warrants further surveillance. For instance, an MDR serotype 35B (non-PCV13) variant of PMEN3 is emerging in the USA and could fill the gap left by the PCV13 serotypes of this clone. 45 The presence of temperate phages is a background characteristic that supports the invasiveness of PMEN3. Recently, their role in virulence and mortality has been linked to PblB, a prophage-encoded 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 Pneumococcal PMEN3: a 30 year history JAC protein with an important role in different infectious disease processes. 46 With the exception of defective PG1, all detected prophages encode PblB proteins. There is also evidence of LytA involvement in pneumococcal virulence 47 and, taking its similarity to the prophage endolysins into account, the latter may also demonstrate immunogenic relevance. It should be realized that fluoroquinolones can induce pneumococcal prophages 46 with a concomitant increase in PblB expression and, presumably, the endolytic enzyme, which may lead to increased virulence. Besides phages, surface proteins also have a role in the pathogenic potential of pneumococci and we found variability in emerging lineages that indicated a wide capacity to interact with host molecules to either increase adhesion or evade the immune system. 18 Nevertheless, the higher prevalence of the preferred combination of surface proteins indicates that such combinations are important to the virulence of PMEN3 through its genetic background.
Our study gives valuable insight into the evolution of PMEN3 over a long period, but does have some important limitations. The selection of only invasive isolates could have meant that we missed events that occurred exclusively in non-invasive isolates, though we consider these putative missed recombinants to be irrelevant because they lose their invasiveness. Limitations also arise from the methodology used; because the identity analysis was based on whether a reference isolate was present, the acquisition of novel genetic material not present in the reference could have remained undetected. Nevertheless, most genetic events that drive the evolution of pneumococci exist in its core genome (e.g. pbp genes, murM and the capsular operon) or are related to transferable elements (phages and resistance associated with ICEs). Given that these have been studied independently, the impact of this limitation should be marginal.
In summary, we have shown how the PMEN3 clone has adapted over the past 30 years in response to the use of broad-spectrum b-lactams and the introduction of conjugate vaccines. The recent emergence of a serotype 11A lineage is a perfect illustration of the ability of this clone to persist over time, regardless of human interventions. In the future, vaccines not based on serotypes may be needed to fight these successful and highly transformable clones.
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